
Reset all filters
01 3AbbVie Inc
02 2Accord healthcare
03 1Bayer AG
04 1Bioglan
05 1DURATA THERAPS INTL
06 1Reig Jofre
07 1Teva Pharmaceutical Industries
08 1Zentiva
Reset all filters
01 1Dalbavancina 500Mg 1 Unit Parenteral Use
02 1POWDER;INTRAVENOUS
03 1Powder For Concentrate And Solution For Infusion
04 8Powder For Concentrate For Solution For Infusion
Reset all filters
01 6Approved
02 3Authorized
03 1RX
04 1Blank
Reset all filters
01 1DALVANCE
02 1Dalbavancin Accord
03 1Dalbavancin Baxter
04 1Dalbavancin Bioglan
05 1Dalbavancin Teva
06 1Dalbavancin Zentiva
07 1Dalbavancina Accord
08 1Dalbavancina Sala
09 3Xydalba
Reset all filters
01 1Italy
02 3Spain
03 6Sweden
04 1USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DALVANCE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 500MG BASE/VIAL
Packaging :
Approval Date : 2014-05-23
Application Number : 21883
Regulatory Info : RX
Registration Country : USA
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Xydalba
Dosage Form : Powder For Concentrate For Solution For Infusion
Dosage Strength : 500mg
Packaging :
Approval Date : 19/02/2015
Application Number : 20131130000029
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Xydalba
Dosage Form : Powder For Concentrate And Solution For Infusion
Dosage Strength : 500MG
Packaging :
Approval Date : 2015-06-27
Application Number : 114986001
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Dalbavancin Accord
Dosage Form : Powder For Concentrate For Solution For Infusion
Dosage Strength : 500mg
Packaging :
Approval Date : 11/06/2024
Application Number : 20230223000066
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Dalbavancina Accord
Dosage Form : Powder For Concentrate For Solution For Infusion
Dosage Strength : 500MG
Packaging :
Approval Date : 2024-05-17
Application Number : 89574
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Dalbavancin Baxter
Dosage Form : Powder For Concentrate For Solution For Infusion
Dosage Strength : 500mg
Packaging :
Approval Date : 08/07/2024
Application Number : 20230227000031
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Dalbavancin Bioglan
Dosage Form : Powder For Concentrate For Solution For Infusion
Dosage Strength : 500mg
Packaging :
Approval Date : 26/04/2024
Application Number : 20230223000011
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info :
Registration Country : Italy
Brand Name : Xydalba
Dosage Form : Dalbavancina 500Mg 1 Unit Parenteral Use
Dosage Strength : 1 bottle groun EV 500 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Dalbavancina Sala
Dosage Form : Powder For Concentrate For Solution For Infusion
Dosage Strength : 500MG
Packaging :
Approval Date : 2024-05-07
Application Number : 89545
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Dalbavancin Teva
Dosage Form : Powder For Concentrate For Solution For Infusion
Dosage Strength : 500mg
Packaging :
Approval Date : 08/07/2024
Application Number : 20230901000074
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Dalbavancin Zentiva
Dosage Form : Powder For Concentrate For Solution For Infusion
Dosage Strength : 500mg
Packaging :
Approval Date : 21/07/2025
Application Number : 20230801000099
Regulatory Info : Approved
Registration Country : Sweden